Send to

Choose Destination
Semin Cutan Med Surg. 2014 Jun;33(3 Suppl):S54-6. doi: 10.12788/j.sder.0093.

Recognizing and managing comorbidities and complications in hidradenitis suppurativa.

Author information

Chief, Division of Dermatology, Baylor University Medical Center; Clinical Professor of Dermatology, University of Texas, Southwestern Medical School; Director, Fellowship Program, Baylor Psoriasis Center; Chair, Psoriasis Guidelines Committee, American Academy of Dermatology; Director, Dermatology Residency Program, Baylor University Medical Center, Dallas, TX.


The list of comorbidities associated with hidradenitis suppurativa (HS) is extensive, although these diseases do not necessarily share a common causality. Among the categories of comorbidities that are observed are obesity, other skin diseases, inflammatory conditions, and genetic disorders. Complications include scarring, restricted movement resulting from scarring and fibrosis in underlying tissue, conditions associated with obstructed lymph drainage, and psychosocial issues. Adverse effects on quality of life are common and may be severe, including unemployment, deterioration of family and other social relationships, and suicidal ideation. Clinical intervention for HS must include consideration and attention to these comorbidities and complications.


Comorbidities; dermatologic diseases; hidradenitis suppurativa; immune-mediated inflammatory diseases; obesity

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Frontline Medical Communications Inc
Loading ...
Support Center